These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18754240)

  • 21. Are claims of advertisements in medical journals supported by RCTs?
    Heimans L; van Hylckama Vlieg A; Dekker FW
    Neth J Med; 2010 Jan; 68(1):46-9. PubMed ID: 20103825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence-based advertising? A survey of four major journals.
    Gutknecht DR
    J Am Board Fam Pract; 2001; 14(3):197-200. PubMed ID: 11355052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal.
    Lexchin J; Holbrook A
    CMAJ; 1994 Jul; 151(1):47-54. PubMed ID: 8004560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaceutical advertisement claims in Australian medical publications.
    Loke TW; Koh FC; Ward JE
    Med J Aust; 2002 Sep; 177(6):291-3. PubMed ID: 12225274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of promotional advertisements of drugs in a medical journal: an ethics perspective.
    Nath S; Bhowmick S; Dutta T; Chowrasia VR; Bhattacharya S; Chatterjee RN; Sarkar M; Ram AK; Mukherjee PK
    Indian J Med Ethics; 2014; 11(4):237-41. PubMed ID: 25377037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Are drug advertisements of any informative value? Analysis of drug advertisements in the Swedish Medical Journal (Läkartidningen) and the Norwegian Medical Journal (Tidsskrift for Den norske laegeforening) during the first half of 1986].
    Stålsby C; Westerholm B
    Tidsskr Nor Laegeforen; 1987 Jun; 107(17-18):1573-7. PubMed ID: 3603531
    [No Abstract]   [Full Text] [Related]  

  • 27. Economic content in medical journal advertisements for medical devices and prescription drugs.
    Ackerly DC; Glickman SW; Schulman KA
    Pharmacoeconomics; 2010; 28(5):429-38. PubMed ID: 20402543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmaceutical advertisements in medical journals received in a medical clinic: are we having "too much of a good thing"?
    Lohiya S
    J Natl Med Assoc; 2005 May; 97(5):718-20. PubMed ID: 15926650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug advertisements published in Indian Medical Journals: Are they ethical?
    Charan J; Yadav P; Saxena D; Kantharia ND
    J Pharm Bioallied Sci; 2011 Jul; 3(3):403-6. PubMed ID: 21966161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advertising in dermatology journals: journals' and journal editors' policies, practices, and attitudes.
    Bartus CL; Katz KA
    J Am Acad Dermatol; 2006 Jul; 55(1):116-22. PubMed ID: 16781302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Claims in advertisements for antihypertensive drugs in a Dutch medical journal.
    Greving JP; Denig P; de Zeeuw D; Haaijer-Ruskamp FM
    J Hypertens; 2007 Mar; 25(3):713-22. PubMed ID: 17278989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are claims made in orthodontic journal advertisements evidence-supported?
    Livas C; Kouskoura T; Ren Y; Katsaros C; Pandis N
    Angle Orthod; 2015 Mar; 85(2):184-8. PubMed ID: 25490551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug advertising as communication between the pharmaceutical industry and the physician: advertisements for psychotropic drugs in the Dutch medical journal, Nederlands Tijdschrift voor Geneeskunde, 1900-1940].
    van der Hoogte AR; Pieters T
    Studium (Rotterdam); 2010; 3(4):139-54. PubMed ID: 22586821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The quantity and quality of scientific graphs in pharmaceutical advertisements.
    Cooper RJ; Schriger DL; Wallace RC; Mikulich VJ; Wilkes MS
    J Gen Intern Med; 2003 Apr; 18(4):294-7. PubMed ID: 12709097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of pharmaceutical advertising and gender bias in medical journals (1998-2008): a review of the scientific literature.
    Cambronero Saiz B; Ruiz Cantero MT; Papí Gálvez N
    Gac Sanit; 2012; 26(5):469-76. PubMed ID: 22265644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How patient outcomes are reported in drug advertisements.
    Lexchin J
    Can Fam Physician; 1999 May; 45():1213-6. PubMed ID: 10349065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct-to-physician and direct-to-consumer advertising: Time to have stringent regulations.
    Kannan S; Gowri S; Tyagi V; Kohli S; Jain R; Kapil P; Bhardwaj A
    Int J Risk Saf Med; 2015; 27(2):77-83. PubMed ID: 26410010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Written drug advertisements--are they reliable?].
    Solhaug HR; Indermo H; Slørdal L; Spigset O
    Tidsskr Nor Laegeforen; 2006 May; 126(10):1314-7. PubMed ID: 16691265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An analysis of advertisements for psychotropic drugs in the Dutch Journal of Psychiatry ('Tijdschrift voor Psychiatrie')].
    Vandereycken W; Kuyken K
    Tijdschr Psychiatr; 2009; 51(6):407-11. PubMed ID: 19517371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health-related quality-of-life claims in prescription drug advertisements.
    Rothermich EA; Pathak DS; Smeenk DA
    Am J Health Syst Pharm; 1996 Jul; 53(13):1565-9. PubMed ID: 8809277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.